Clinical Response to Regenerative Therapies for Erectile Dysfunction: A Systematic Review and Meta-Analysis of Responder Outcomes
Journal of Clinical Medicine · 13.11.2026 · 15 (22) · 8895
DOI: 10.3390/jcm15228895 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.11.2026. Verfasst von Rustam Omarbayev und 5 weiteren Autor:innen. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
Background/Objectives: Regenerative therapies are increasingly used for organic erectile dysfunction (ED), but their effects on erectile function and clinically meaningful response remain uncertain. We evaluated erectile-function scores, penile hemodynamics, and responder outcomes.
Methods
We searched PubMed, Scopus, and Cochrane CENTRAL from January 1999 to June 2026. Controlled, active-comparator, and uncontrolled studies were analysed separately. Random-effects models synthesised continuous and responder outcomes by follow-up period. We assessed risk of bias using RoB 2 and ROBINS-I and rated certainty of evidence using GRADE.
Results
We included 46 study reports comprising 18 randomized trials and 28 non-randomized studies. In controlled comparisons, mean International Index of Erectile Function (IIEF) scores favored treatment at short-term follow-up (≤12 weeks; Hedges’ g = 1.08, 95% CI 0.64–1.52). The mid-term estimate was less precise (13–24 weeks; g = 0.49, 95% CI −0.02 to 1.01). Controlled Erection Hardness Score estimates were also imprecise. Risk ratios for study-defined clinically meaningful improvement in the IIEF erectile function domain were 2.51 (95% CI 0.76–8.31), 2.62 (0.56–12.36), and 2.67 (0.58–12.22) at 4, 12, and 24 weeks, respectively. Exploratory within-group analyses showed post-treatment changes in erectile function and peak systolic velocity, with substantial heterogeneity across several analyses.
Conclusions
Controlled studies favored regenerative therapies for short-term improvement in mean erectile-function scores. Whether more patients achieve a clinically meaningful response, how long any benefit lasts, and which therapies are most effective remain uncertain. The review was registered with PROSPERO (CRD420261421415).
Förderung
- Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Omarbayev, R., Iskakov, Y., Orassay, A., Nugumanov, R., Paizullayeva, S., & Askarov, M. (2026). Clinical Response to Regenerative Therapies for Erectile Dysfunction: A Systematic Review and Meta-Analysis of Responder Outcomes. Journal of Clinical Medicine, 15(22), 8895. https://doi.org/10.3390/jcm15228895
Vancouver
Omarbayev R, Iskakov Y, Orassay A, Nugumanov R, Paizullayeva S, Askarov M. Clinical Response to Regenerative Therapies for Erectile Dysfunction: A Systematic Review and Meta-Analysis of Responder Outcomes. Journal of Clinical Medicine. 2026;15(22):8895. doi:10.3390/jcm15228895
BibTeX
@article{Omarbayev2026,
author = {Omarbayev, Rustam and Iskakov, Yerbol and Orassay, Aliya and Nugumanov, Rinat and Paizullayeva, Saule and Askarov, Manarbek},
title = {Clinical Response to Regenerative Therapies for Erectile Dysfunction: A Systematic Review and Meta-Analysis of Responder Outcomes},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {22},
pages = {8895},
doi = {10.3390/jcm15228895}
}
EUVIMED